Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related

Diagnosis of hepatocellular carcinoma (HCC) in early-stage, to give an effective treatment option and improve quality of life for cancer patients, is an important medical mission globally. Combination of AFP with some biomarkers may be more supportive in both diagnosis and screening of HCC, but the...

Full description

Bibliographic Details
Main Authors: Hoang Bac Nguyen, Xuan-Thao Thi Le, Huy Huu Nguyen, Thanh Thanh Vo, Minh Khoi Le, Ngan Trung Nguyen, Thien Minh Do-Nguyen, Cong Minh Truong-Nguyen, Bang-Suong Thi Nguyen
Format: Article
Language:English
Published: SAGE Publishing 2022-05-01
Series:Cancer Informatics
Online Access:https://doi.org/10.1177/11769351221100730
_version_ 1811257443392421888
author Hoang Bac Nguyen
Xuan-Thao Thi Le
Huy Huu Nguyen
Thanh Thanh Vo
Minh Khoi Le
Ngan Trung Nguyen
Thien Minh Do-Nguyen
Cong Minh Truong-Nguyen
Bang-Suong Thi Nguyen
author_facet Hoang Bac Nguyen
Xuan-Thao Thi Le
Huy Huu Nguyen
Thanh Thanh Vo
Minh Khoi Le
Ngan Trung Nguyen
Thien Minh Do-Nguyen
Cong Minh Truong-Nguyen
Bang-Suong Thi Nguyen
author_sort Hoang Bac Nguyen
collection DOAJ
description Diagnosis of hepatocellular carcinoma (HCC) in early-stage, to give an effective treatment option and improve quality of life for cancer patients, is an important medical mission globally. Combination of AFP with some biomarkers may be more supportive in both diagnosis and screening of HCC, but the range value of these markers can be applied as daily markers were unclearly. In some studies, human telomerase reverse transcriptase (hTERT mRNA) was reported as an advantage marker to diagnose cancer. The present study identified serum of 340 patients that were infected chronic hepatitis B virus or hepatitis C virus and divided in 2 groups including Hepatocellular carcinoma (HCC) and liver cirrhosis (LC) to measure their values of hTERT mRNA, AFP, AFP-L3%, and DCP, as well as combination of them. As a result, the concentration of hTERT mRNA, AFP, AFP-L3%, and DCP in HCC groups were significantly higher than that in LC group ( P  < .01). For detecting HCC, hTERT mRNA had sensitivity of 88% and specificity of 96% (at the cutoff value of 31.5 copies/mL), AFP sensitivity of 73% and specificity of 92% (at the cutoff value of 5.1 ng/mL), AFP-L3% sensitivity of 69% and specificity of 90% (at the cutoff value of 1.05%), DCP sensitivity of 82% and specificity of 92% (at the cutoff value of 29.01 mAU/mL). The largest area under the curve (AUC) of combination hTERT mRNA with DCP was 0.932 (sensitivity of 98.2% and specificity of 88.2%). New combination of DCP with hTERT mRNA gave a useful choice for screening of HCC in chronic HBV or HCV patients associated liver cirrhosis.
first_indexed 2024-04-12T17:57:19Z
format Article
id doaj.art-7a52e17ac6f3499b818769566a6132ef
institution Directory Open Access Journal
issn 1176-9351
language English
last_indexed 2024-04-12T17:57:19Z
publishDate 2022-05-01
publisher SAGE Publishing
record_format Article
series Cancer Informatics
spelling doaj.art-7a52e17ac6f3499b818769566a6132ef2022-12-22T03:22:18ZengSAGE PublishingCancer Informatics1176-93512022-05-012110.1177/11769351221100730Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-RelatedHoang Bac NguyenXuan-Thao Thi LeHuy Huu NguyenThanh Thanh VoMinh Khoi LeNgan Trung NguyenThien Minh Do-NguyenCong Minh Truong-NguyenBang-Suong Thi NguyenDiagnosis of hepatocellular carcinoma (HCC) in early-stage, to give an effective treatment option and improve quality of life for cancer patients, is an important medical mission globally. Combination of AFP with some biomarkers may be more supportive in both diagnosis and screening of HCC, but the range value of these markers can be applied as daily markers were unclearly. In some studies, human telomerase reverse transcriptase (hTERT mRNA) was reported as an advantage marker to diagnose cancer. The present study identified serum of 340 patients that were infected chronic hepatitis B virus or hepatitis C virus and divided in 2 groups including Hepatocellular carcinoma (HCC) and liver cirrhosis (LC) to measure their values of hTERT mRNA, AFP, AFP-L3%, and DCP, as well as combination of them. As a result, the concentration of hTERT mRNA, AFP, AFP-L3%, and DCP in HCC groups were significantly higher than that in LC group ( P  < .01). For detecting HCC, hTERT mRNA had sensitivity of 88% and specificity of 96% (at the cutoff value of 31.5 copies/mL), AFP sensitivity of 73% and specificity of 92% (at the cutoff value of 5.1 ng/mL), AFP-L3% sensitivity of 69% and specificity of 90% (at the cutoff value of 1.05%), DCP sensitivity of 82% and specificity of 92% (at the cutoff value of 29.01 mAU/mL). The largest area under the curve (AUC) of combination hTERT mRNA with DCP was 0.932 (sensitivity of 98.2% and specificity of 88.2%). New combination of DCP with hTERT mRNA gave a useful choice for screening of HCC in chronic HBV or HCV patients associated liver cirrhosis.https://doi.org/10.1177/11769351221100730
spellingShingle Hoang Bac Nguyen
Xuan-Thao Thi Le
Huy Huu Nguyen
Thanh Thanh Vo
Minh Khoi Le
Ngan Trung Nguyen
Thien Minh Do-Nguyen
Cong Minh Truong-Nguyen
Bang-Suong Thi Nguyen
Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
Cancer Informatics
title Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
title_full Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
title_fullStr Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
title_full_unstemmed Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
title_short Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related
title_sort diagnostic value of htert mrna and in combination with afp afp l3 des γ carboxyprothrombin for screening of hepatocellular carcinoma in liver cirrhosis patients hbv or hcv related
url https://doi.org/10.1177/11769351221100730
work_keys_str_mv AT hoangbacnguyen diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT xuanthaothile diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT huyhuunguyen diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT thanhthanhvo diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT minhkhoile diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT ngantrungnguyen diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT thienminhdonguyen diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT congminhtruongnguyen diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated
AT bangsuongthinguyen diagnosticvalueofhtertmrnaandincombinationwithafpafpl3desgcarboxyprothrombinforscreeningofhepatocellularcarcinomainlivercirrhosispatientshbvorhcvrelated